Alburex-25 (2019-02-07)
- Starting date:
- February 7, 2019
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type II
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-69014
Recalled Products
Alburex-25 Solution
Reason
Appearance may be out of specification in the affected lot.
Depth of distribution
Quebec Hospitals
Affected products
Alburex-25 Solution
DIN, NPN, DIN-HIM
DIN 02274663
Dosage form
Solution
Strength
Albumin (Human) 25%
Lot or serial number
P100009373
Companies
- Recalling Firm
-
CSL Behring Canada Inc.
Suite 1460, 55 Metcalfe Street,
Ottawa
K1P 6L5
Ontario
CANADA
- Marketing Authorization Holder
-
CSL Behring Canada Inc.
Suite 1460, 55 Metcalfe Street,
Ottawa
K1P 6L5
Ontario
CANADA